anonymous
Guest
anonymous
Guest
Just saw a banner on Healio Ocular Surgery news that Genentech is the “Future of ophthalmology “. Interesting, let’s see what the market ends up saying.
They’ll pull the plug when the annual revenue is below a billion, which should be in 2020. There is no need for reps at this point. They’re irrelevant
Troll.
That's because FRMs do nothing. Sit home all day. Fact.
Worthless FDM’s did nothing just a few years ago before the bloodletting.
What happened to Alicia? Anyone know? That was abrupt.